BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23738683)

  • 81. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
    Fan YL; Li XQ
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract][Full Text] [Related]  

  • 83. How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.
    Couto JP; Prazeres H; Castro P; Lima J; Máximo V; Soares P; Sobrinho-Simões M
    J Clin Pathol; 2009 May; 62(5):414-21. PubMed ID: 19147628
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma.
    Nakabashi CC; Guimarães GS; Michaluart P; Ward LS; Cerutti JM; Maciel RM
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):280-2. PubMed ID: 15272927
    [No Abstract]   [Full Text] [Related]  

  • 85. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer.
    Zhang Y; Yu J; Grachtchouk V; Qin T; Lumeng CN; Sartor MA; Koenig RJ
    Oncotarget; 2017 Jan; 8(4):5761-5773. PubMed ID: 28008156
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas.
    Aldred MA; Morrison C; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang S; Eng C
    Oncogene; 2003 May; 22(22):3412-6. PubMed ID: 12776192
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma.
    Krause K; Prawitt S; Eszlinger M; Ihling C; Sinz A; Schierle K; Gimm O; Dralle H; Steinert F; Sheu SY; Schmid KW; Fuhrer D
    Am J Pathol; 2011 Dec; 179(6):3066-74. PubMed ID: 21983636
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In Silico Search for Drug Candidates Targeting the PAX8-PPARγ Fusion Protein in Thyroid Cancer.
    Sakaguchi K; Okiyama Y; Tanaka S
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791384
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms.
    Sanii S; Saffar H; Tabriz HM; Qorbani M; Haghpanah V; Tavangar SM
    Asian Pac J Cancer Prev; 2012; 13(5):2175-8. PubMed ID: 22901190
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
    Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
    Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pax-8-PPAR-γ fusion protein in thyroid carcinoma.
    Raman P; Koenig RJ
    Nat Rev Endocrinol; 2014 Oct; 10(10):616-23. PubMed ID: 25069464
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop.
    Vieira JM; Santos SC; Espadinha C; Correia I; Vag T; Casalou C; Cavaco BM; Catarino AL; Dias S; Leite V
    Eur J Endocrinol; 2005 Nov; 153(5):701-9. PubMed ID: 16260429
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma.
    Takano T
    Pathol Int; 2011 Mar; 61(3):165-6. PubMed ID: 21355960
    [No Abstract]   [Full Text] [Related]  

  • 95. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck.
    Bishop JA; Sharma R; Westra WH
    Hum Pathol; 2011 Dec; 42(12):1873-7. PubMed ID: 21663937
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.
    Nikita ME; Jiang W; Cheng SM; Hantash FM; McPhaul MJ; Newbury RO; Phillips SA; Reitz RE; Waldman FM; Newfield RS
    Thyroid; 2016 Feb; 26(2):227-34. PubMed ID: 26649796
    [TBL] [Abstract][Full Text] [Related]  

  • 97. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).
    Oliveira G; Polónia A; Cameselle-Teijeiro JM; Leitão D; Sapia S; Sobrinho-Simões M; Eloy C
    Virchows Arch; 2017 May; 470(5):517-525. PubMed ID: 28236059
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [The analysis of genetic and clinicopathologic characteristics in patients with follicular thyroid neoplasm].
    Zhang J; Li Y; Lyu N; Ying JM
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):594-598. PubMed ID: 31434450
    [No Abstract]   [Full Text] [Related]  

  • 99. PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid.
    Marchiò C; Da Cruz Paula A; Gularte-Merida R; Basili T; Brandes A; da Silva EM; Silveira C; Ferrando L; Metovic J; Maletta F; Annaratone L; Pareja F; Rubin BP; Hoschar AP; De Rosa G; La Rosa S; Bongiovanni M; Purgina B; Piana S; Volante M; Weigelt B; Reis-Filho JS; Papotti M
    Mod Pathol; 2019 Dec; 32(12):1734-1743. PubMed ID: 31273314
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Underexpression of PPARgamma is associated with aneuploidy and lower differentiation of thyroid tumours of follicular origin.
    Espadinha C; Pinto AE; Leite V
    Oncol Rep; 2009 Oct; 22(4):907-13. PubMed ID: 19724872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.